Loop Capital upgraded shares of Enovix (NASDAQ:ENVX – Free Report) to a strong-buy rating in a report issued on Monday morning,Zacks.com reports.
Several other brokerages also recently issued reports on ENVX. B. Riley Financial cut their price target on Enovix from $10.00 to $9.00 and set a “buy” rating for the company in a report on Thursday, August 13th. Canaccord Genuity Group dropped their price objective on Enovix from $15.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 14th. JPMorgan Chase & Co. lowered Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Craig Hallum set a $7.00 price target on Enovix in a research report on Thursday, August 13th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $11.77.
Get Our Latest Stock Report on Enovix
Enovix Price Performance
Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. The firm had revenue of $9.02 million during the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The business’s revenue was up 20.8% compared to the same quarter last year. During the same period last year, the company earned ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, sell-side analysts forecast that Enovix will post -0.78 EPS for the current fiscal year.
Hedge Funds Weigh In On Enovix
A number of institutional investors have recently added to or reduced their stakes in the stock. Flputnam Investment Management Co. boosted its position in Enovix by 36.9% in the second quarter. Flputnam Investment Management Co. now owns 142,608 shares of the company’s stock valued at $866,000 after buying an additional 38,453 shares in the last quarter. Hsbc Holdings PLC boosted its holdings in shares of Enovix by 69.7% during the 2nd quarter. Hsbc Holdings PLC now owns 42,150 shares of the company’s stock valued at $261,000 after acquiring an additional 17,319 shares in the last quarter. Beacon Pointe Advisors LLC bought a new stake in Enovix during the 2nd quarter worth $290,000. Equitable Holdings Inc. acquired a new position in Enovix in the 2nd quarter worth about $86,000. Finally, Corient Private Wealth LP bought a new position in Enovix in the second quarter valued at about $322,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Enovix
Here are the key news stories impacting Enovix this week:
- Positive Sentiment: Buy upgrade and improving estimates: Zacks upgraded Enovix to Rank #2 (Buy), citing growing optimism about the company’s earnings outlook. Separately, Zacks said ENVX is technically oversold after a steep four-week decline, while analysts have been revising earnings estimates higher—factors that could support a near-term rebound. Enovix upgraded to Buy Why Enovix’s trend might reverse
- Positive Sentiment: CEO transition described as strategic continuity: Enovix said the leadership change is a “CEO transition, not a strategy transition,” reaffirmed its third-quarter 2026 guidance, and reported approximately $552 million in cash. The sizable cash balance may ease near-term financing concerns and support continued development. Enovix CEO transition webcast
- Neutral Sentiment: Unusually high trading activity in Enovix call options indicates elevated speculative interest, but the report does not establish whether investors are positioning for a sustained rally or further volatility. Enovix call option activity
- Negative Sentiment: Analyst downgrade and recent low: William Blair cut ENVX to Market Perform, and the stock recently reached a new 12-month low after the downgrade. Reports also attributed the broader decline in battery-development stocks to sharply higher Treasury yields, which pressure speculative companies. William Blair downgrades Enovix Higher yields pressure speculative growth stocks
About Enovix
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Stories
- Five stocks we like better than Enovix
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
